Lv1
60 积分 2023-05-19 加入
CircMIIP Contributes to Non-Small Cell Lung Cancer Progression by Binding miR-766-5p to Upregulate FAM83A Expression
20天前
已完结
Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3
20天前
已完结
Circ_0006324 regulates cell proliferation, cell‐cycle progression, apoptosis, and glycolysis of non‐small cell lung cancer cells through miR‐496/TRIM59 axis
20天前
已完结
Omitting Lymph Node Dissection for Small Ground-Glass Opacity–Dominant Tumors
4个月前
已完结
Identification and Validation of Amino Acid Metabolism-Related Biomarkers and Investigation of their Potential Mechanisms in Lung Adenocarcinoma
5个月前
已完结
The role of the immune tumor microenvironment in shaping metastatic dissemination, dormancy, and outgrowth
6个月前
已完结
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
6个月前
已完结
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
6个月前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
7个月前
已完结
Nedaplatin Plus Docetaxel Versus Cisplatin Plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung — A Multicenter, Open-label, Randomized, Phase III Trial
7个月前
已完结
皖公网安备34019202002308
